Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07195461 · ClinicalTrials.gov registry record · Early Phase 1

Feasibility Study Evaluating the Safety and Effectiveness of Magnetic Bead Tracking System When Used With a Bionic External Prosthesis

A Early Phase 1 study of Transtibial Amputation and Transtibial Amputee, sponsored by MuscleMetrix.

Recruiting
Registry status
Early Phase 1
Development phase
3
Enrollment target
1
Study location

NCT07195461 is a Early Phase 1 study of Transtibial Amputation and Transtibial Amputee that is actively recruiting participants, run by MuscleMetrix. The registered enrollment target is 3 participants, below the 37-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07195461, a Early Phase 1 study of Transtibial Amputation and Transtibial Amputee, is actively recruiting participants, sponsored by MuscleMetrix.

RECRUITING
Registry status
Early Phase 1
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

The investigation is an early feasibility study in up to 5 subjects, in which the primary objective is to capture preliminary safety and effectiveness information on the Magnetic Bead Tracking system.

Interventions

  • DEVICE Magnetic Bead Tracking System

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2025-09-11
Est. Completion 2026-04
Phase Early Phase 1

Sponsor

MuscleMetrix

1 total trials

What the Registry Record Tells You About NCT07195461

The ClinicalTrials.gov registry entry for NCT07195461 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 37-participant average among 4 other Transtibial Amputation trials with a reported enrollment target (92% lower). The listed sponsor is MuscleMetrix, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Transtibial Amputation appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Bead Tracking System is the first listed.

NCT07195461 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07195461 about?

NCT07195461 is a clinical study titled "Feasibility Study Evaluating the Safety and Effectiveness of Magnetic Bead Tracking System When Used With a Bionic External Prosthesis". The investigation is an early feasibility study in up to 5 subjects, in which the primary objective is to capture preliminary safety and effectiveness information on the Magnetic Bead Tracking system.

What is the current status of trial NCT07195461?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2025-09-11. Estimated completion is 2026-04.

What conditions does trial NCT07195461 study?

This clinical trial studies the following conditions: Transtibial Amputation, Transtibial Amputee.

What interventions are being tested in trial NCT07195461?

The interventions under investigation include: Magnetic Bead Tracking System (DEVICE).

Who is sponsoring clinical trial NCT07195461?

This trial is sponsored by MuscleMetrix, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07195461 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Transtibial Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.